ENS
EnerSys
ENS has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.
RKLB
Rocket Lab USA, Inc.
RKLB's outlook is improving, though it still trails on the overall score.
ENS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
ENS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ENS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $148 | — |
| Cheap | 14x | $138 | -6.6% |
| Current | 15x | $148 | — |
| Fair | 20x | $196 | +33% |
| Expensive | 26x | $257 | +74% |
Historical ranges are pointers, not guarantees.
ENS's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ENS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ENS, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ENS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.56 | +36% |
| Q3 2026 | $9.95 | +17% |
| Q2 2026 | $9.33 | +6.8% |
| Q1 2026 | $7.70 | -14% |
| Q4 2025 | $8.05 | -0.4% |
| Q3 2025 | $8.53 | +21% |
| Q2 2025 | $8.74 | +32% |
| Q1 2025 | $8.99 | +38% |
| Q4 2024 | $8.08 | +22% |
ENS has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ENS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $949.9M | -0.1% |
| Q2 2026 | $935.6M | +4.8% |
| Q1 2026 | $987.9M | +1.3% |
| Q4 2025 | $919.1M | +1.4% |
| Q3 2025 | $951.3M | +7.7% |
| Q2 2025 | $893M | +4.7% |
| Q1 2025 | $974.8M | +7% |
| Q4 2024 | $906.2M | +5.2% |
ENS's revenue grew through 2022 and has held roughly level since: $950M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +2.5 points |
| Q2 2026 | 16% | +6.5 points |
| Q1 2026 | 13% | -1 points |
| Q4 2025 | 14% | -2.2 points |
| Q3 2025 | 9.7% | -1.6 points |
| Q2 2025 | 9.7% | -1 points |
| Q1 2025 | 13% | +4.6 points |
| Q4 2024 | 16% | +5 points |
ENS has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ENS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ENS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $130.3M | -34% |
| Q2 2026 | $217.7M | +$249.8M |
| Q1 2026 | $131.2M | +25% |
| Q4 2025 | $171.3M | +202% |
| Q3 2025 | $197.1M | +5876% |
| Q2 2025 | -$32.1M | -$6.3M |
| Q1 2025 | $104.9M | -4.1% |
| Q4 2024 | $56.8M | -49% |
ENS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ENS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -669K shares |
| 1 year | -2.7% | -1M shares |
| 3 years | -11% | -4.7M shares |
| 5 years | -15% | -6.3M shares |
| Available history | -14% | -5.9M shares |
ENS has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $130M |
| Q2 2026 | $50M |
| Q1 2026 | $69.3M |
| Q4 2025 | $83.6M |
| Q3 2025 | $67.8M |
| Q2 2025 | $150M |
| Q1 2025 | $40M |
| Q4 2024 | $38.7M |
ENS spent $333M buying back its own shares over the past year, up 12% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ENS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.6x | Healthy |
ENS's net debt is less than a year of its operating earnings (EBITDA), down from 1.5 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ENS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 5.8 | Oversold |
ENS's weekly RSI is 32 (neutral) and its Stochastic is 6 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ENS PE vs Industrials Sector
| Metric | ENS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 24x | 38% below |
| PE % | 22 | 58 | 36 pts below |
ENS is trading at 15x earnings, a 38% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ENS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $168.1 | 12% below |
| 20 week MA | $182.0 | 19% below |
| 50 week MA | $184.5 | 20% below |
| 100 week MA | $142.3 | 3.9% above |
| 200 week MA | $118.9 | 24% above |
ENS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 24% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over ENS on trend strength, trading above more of its moving averages.
ENS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $75.5 | $83.3 | +10% |
| 2021 | $83.3 | $77.5 | -6.9% |
| 2022 | $77.5 | $73.0 | -5.8% |
| 2023 | $73.0 | $101.0 | +38% |
| 2024 | $101.0 | $92.7 | -8.2% |
| 2025 | $92.7 | $151.0 | +63% |
| 2026 YTD | $151.0 | $147.8 | -2.1% |
ENS has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.